Welcome to our new website! Please follow us to stay up to date.
Jan. 17, 2023

Season 2 Episode 1: An interview with Jeff Galvin, the CEO and Founder of American Gene Technologies

Join us on the Biotech Project podcast as we sit down with Jeff Galvin, the CEO and Founder of American Gene Technologies. Jeff is a visionary in the field of gene therapy and has been at the forefront of developing innovative treatments. In this epi...


Join us on the Biotech Project podcast as we sit down with Jeff Galvin, the CEO and Founder of American Gene Technologies. Jeff is a visionary in the field of gene therapy and has been at the forefront of developing innovative treatments. In this episode, we delve into the inner workings of American Gene Technologies, the company's current projects and pipeline, including their goal of curing HIV. We also explore the challenges and opportunities facing the biotech industry.

Additionally, Jeff will share his insights on the future of gene therapy and the impact it will have on healthcare. Tune in to gain an in-depth understanding of the future of gene therapy from one of its leading figures.

Jeff Galvin Profile Photo

Jeff Galvin

CEO and Founder of American Gene Technologies®

Jeff Galvin is the CEO and Founder of American Gene Technologies®. He earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies, including one in the medical-technology arena that was sold to Varian, the leading maker of linear accelerators used in cancer therapy. Following his startup experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement to found and fund AGT™ after meeting Roscoe Brady at NIH.